Urology Times Innovation Celebration Video Series : Episode 12
Video
Urology Times 50 Innovations Series: Extracorporeal shock wave lithotripsy for stones
Author(s):
"The seminal innovation was the idea that you could create a focused shock wave that could be delivered into the body in a non-invasive way that had sufficient energy to break up a stone but not damage other structures," says James E. Lingeman, MD.
Video Player is loading.
Urology Times® is celebrating its 50th anniversary in 2022. To mark the occasion, we are high-lighting 50 of the top innovations and developments that have transformed the field of urology over the past 50 years. In this installment, James E. Lingeman, MD, discusses the development of ex-tracorporeal shock wave lithotripsy for the treatment of kidney stones. Lingeman is a professor of clinical urology at Indiana University School of Medicine in Indianapolis.
Related Videos
BLUES trial: Silicone stents may improve patient care
Roshan Patel, MD, on the impact of restricted irrigation on PCNL outcomes
Jared S. Winoker, MD, discusses real-world study of CVAC 2.0 for kidney stones
Study results show CVAC 2.0 is safe, efficacious for wide range of kidney stones
Amir Patel, MD, on ureteral strictures following holmium vs TFL laser lithotripsy
Sarah Razavi, MD, discusses the physical toll of ureteroscopy on urologists
Joshua Heiman, MD, on phentermine plus topiramate for uric acid stone prevention
Investigators evaluate patient outcomes with silicone vs polyurethane stents
John Michael DiBianco, MD, on silicone vs polyurethane stents for patients with kidney stones
Khurshid Ghani, MD, on trial of stent omission following ureteroscopy
Related Content
